Sign in
Taking people in United StatesNo phase

Studying the heart's electrical signals in ventricular tachycardia

Tests a catheter measuring heart tissue's electrical activity in adults with ventricular tachycardia.

Key facts

Who runs it
Emory University
Where
Atlanta, United StatesSee the 3 sites
Trial code
Registry title
Ventricular Tachycardia Mechanisms
Status
Recruiting
People taking part
10 people, planned
Started
25 Oct 2022
Expected to end
May 2027
Type of study
Interventional
Treatments tested
  • Monophasic Action Potential (MAP) Catheter
Record updated
30 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with ischemic cardiomyopathy who have an ICD and are having a ventricular tachycardia (VT) ablation. Ischemic cardiomyopathy is heart muscle damage from poor blood flow.

Age
18 Years and older
Sex
All
Disease stage
Ischemic cardiomyopathy (heart muscle damage caused by reduced blood flow to the heart).
Earlier treatment
Must have a single or dual chamber implantable cardioverter-defibrillator (ICD), a device that shocks the heart back to a normal rhythm.

Main reasons for not taking part

  • Non-ischemic cardiomyopathy
  • A reason you cannot have catheter ablation
  • Severe peripheral arterial disease or another condition that blocks access through an artery
  • VT or sudden cardiac arrest within 30 days of acute coronary syndrome (heart attack or unstable angina)
  • VT or sudden cardiac arrest within 90 days of a procedure to reopen heart arteries

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Diagnosis of ischemic cardiomyopathy
  • Single or dual chamber implantable cardioverter-defibrillator (ICD)

Who cannot take part

  • Severe peripheral arterial disease or medical condition that prohibit arterial access
  • Ventricular tachycardia (VT) or sudden cardiac arrest (SCA) within 30 days of acute coronary syndrome or within 90 days of coronary revascularization
  • Non-Ischemic cardiomyopathy
  • Contraindication to catheter ablation

Where in United States

  • Emory ClinicAtlanta, United StatesContact: Neal Bhatia, MDTaking people
  • Emory University HospitalAtlanta, United StatesContact: Neal Bhatia, MDTaking people
  • Emory University Hospital MidtownAtlanta, United StatesContact: Neal Bhatia, MDTaking people

About the trial

What the trial wants to find out

The purpose of this study is to understand why certain hearts have ventricular arrhythmias and help identify areas of the heart that cause arrhythmias. There is still a significant gap in understanding why ventricular arrhythmias occur. This study will examine the electrical properties of the heart tissue to understand how these arrhythmias occur, and hopefully identify areas that might lead to ventricular arrhythmias. The hope is that studying this might be able to improve outcomes during ventricular tachycardia (VT) ablations.

The group in the trial

  • Monophasic Action Potential (MAP) CatheterTreatment being tested

    Participants undergoing ventricular tachycardia ablation per standard of care will also have cellular action potential of the ventricular myocardium assessed with the MAP catheter.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Ventricular Tachycardia Substrate Mechanisms Revealed by Local Repolarization and Conduction Parameters
Plain-language title
Studying the heart's electrical signals in ventricular tachycardiaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
30 June 2026